| Literature DB >> 34011070 |
Yoon Jae Lee1, Byeong-Gu Gang2, Chang Jun Kum2, Keunjae Lee2, Young Suk Yoon2, Jinho Lee2, Joon-Shik Shin2, In-Hyuk Ha1.
Abstract
ABSTRACT: Although collaborative treatment by traditional Korean medicine doctors (KMDs) and medical doctors occurs, it is mainly done by referral. As no survey of the general public's preference for the type of collaboration has ever been conducted, we aimed to investigate Koreans' preferences for a collaborative treatment type.The responders were extracted by random digit dialing and then reextracted using the proportional quota sampling method by sex and age. From July to October 2017, telephone interviews were conducted and the participant responses regarding treatment history for spinal or joint diseases, experiences with collaborative treatment, and preferred type of collaborative treatment were recorded.Of the 1008 respondents, 44.64% reported a history of treatment for spinal or joint diseases at a medical institution. The concurrent collaborative treatment system, in which both KMDs and medical doctors are present in one location participating in the treatment concurrently, was the most preferred system among the respondents. Respondents who reported experience with traditional Korean medicine hospitals were more likely to prefer a one-stop treatment approach than those who did not have experience with traditional Korean medicine hospitals (adjusted odds ratio: 1.73; 95% confidence interval: 1.12-2.68). Respondents who were familiar with collaborative treatment but did not report any personal experience with it were more likely to prefer a one-stop treatment approach than those who were not familiar with collaborative treatment (adjusted odds ratio: 1.82; 95% confidence interval: 1.37-2.44).Koreans prefer a concurrent type of collaborative treatment system by KMDs and medical doctors. Therefore, efforts and support are needed to increase the application of the concurrent type of collaborative system.Entities:
Mesh:
Year: 2021 PMID: 34011070 PMCID: PMC8137069 DOI: 10.1097/MD.0000000000025939
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Demographic characteristics of respondents (n = 1008).
| n | (%) | |
| Age, years∗ 51.62 ± 10.54 | ||
| 35≤ < 40 | 144 | 14.29 |
| 40≤ < 50 | 310 | 30.75 |
| 50≤ < 60 | 302 | 29.96 |
| 60≤ < 70 | 190 | 18.85 |
| 70≤ < 75 | 62 | 6.15 |
| Sex | ||
| Male | 503 | 49.9 |
| Female | 505 | 50.1 |
| Region | ||
| Seoul | 194 | 19.25 |
| Incheon/Gyeonggi | 301 | 29.86 |
| Pusan/Daegu/Ulsan/Gyeongsang | 266 | 26.39 |
| Gwangju/Jeolla | 101 | 10.02 |
| Daejeon/Sejong/Chungcheong | 103 | 10.22 |
| Gangwon/Jeju | 43 | 4.27 |
| Spinal or joint disease treatment | ||
| Yes | 450 | 44.64 |
| No | 558 | 55.36 |
Respondents’ spine and joint disease history (n = 450).
| Herniated cervical disc | Herniated lumbar disc | Spinal stenosis | Degenerative spine conditions | Myalgia (Sprain) | Joint disorders | Others | No memory/unknown | |||||||||
| n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | |
| Total | ||||||||||||||||
| 46 | 10.22 | 108 | 24.00 | 68 | 15.11 | 15 | 3.33 | 86 | 19.11 | 98 | 21.78 | 25 | 5.56 | 4 | 0.89 | |
| Age | ||||||||||||||||
| 35≤ < 40 | 7 | 16.28 | 16 | 37.21 | 2 | 4.65 | 0 | 0.00 | 10 | 23.26 | 7 | 16.28 | 1 | 2.33 | 0 | 0.00 |
| 40≤ < 50 | 14 | 11.97 | 32 | 27.35 | 12 | 10.26 | 0 | 0.00 | 30 | 25.64 | 19 | 16.24 | 9 | 7.69 | 1 | 0.85 |
| 50≤ < 60 | 19 | 12.67 | 33 | 22.00 | 21 | 14.00 | 7 | 4.67 | 30 | 20.00 | 31 | 20.67 | 9 | 6.00 | 0 | 0.00 |
| 60≤ < 70 | 4 | 4.12 | 18 | 18.56 | 22 | 22.68 | 6 | 6.19 | 11 | 11.34 | 31 | 31.96 | 3 | 3.09 | 2 | 2.06 |
| 70≤ < 75 | 2 | 4.65 | 9 | 20.93 | 11 | 25.58 | 2 | 4.65 | 5 | 11.63 | 10 | 23.26 | 3 | 6.98 | 1 | 2.33 |
| Sex | ||||||||||||||||
| Male | 23 | 10.22 | 62 | 27.56 | 33 | 14.67 | 7 | 3.11 | 43 | 19.11 | 38 | 16.89 | 18 | 8.00 | 1 | 0.44 |
| Female | 23 | 10.22 | 46 | 20.44 | 35 | 15.56 | 8 | 3.56 | 43 | 19.11 | 60 | 26.67 | 7 | 3.11 | 3 | 1.33 |
Respondents’ use of types of medical institutions (duplication allowed) (n = 450).
| Conventional medicine (n = 408) | Korean medicine (n = 235) | Other (n = 10) | ||||||||||||||||
| Total | Primary care hospital (orthopedics, hospital, etc.) | Local clinic (orthopedics, rehabilitation medicine, etc.) | Spine-specialty hospital (conventional medicine) | University or general hospital | Total | Korean medicine hospital | Spine-specialty Korean medicine hospital | Others | ||||||||||
| n | % | n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | |
| Age | ||||||||||||||||||
| 35≤ < 40 | 36 | 8.82 | 18 | 49.02 | 16 | 3.92 | 6 | 65.36 | 6 | 1.47 | 25 | 10.64 | 9 | 3.83 | 2 | 0.85 | 1 | 10 |
| 40≤ < 50 | 109 | 26.72 | 67 | 39.87 | 40 | 9.80 | 15 | 65.36 | 20 | 4.90 | 60 | 25.53 | 13 | 5.53 | 7 | 2.98 | 3 | 30 |
| 50≤ < 60 | 135 | 33.09 | 87 | 38.03 | 42 | 10.29 | 20 | 51.47 | 28 | 6.86 | 80 | 34.04 | 24 | 10.21 | 12 | 5.11 | 1 | 10 |
| 60≤ < 70 | 87 | 21.32 | 46 | 46.36 | 35 | 8.58 | 16 | 53.62 | 19 | 4.66 | 51 | 21.70 | 17 | 7.23 | 4 | 1.70 | 3 | 30 |
| 70≤ < 75 | 41 | 10.05 | 21 | 47.85 | 17 | 4.17 | 8 | 52.08 | 16 | 3.92 | 19 | 8.09 | 9 | 3.83 | 2 | 0.85 | 2 | 20 |
| Sex | ||||||||||||||||||
| Male | 202 | 49.51 | 113 | 43.81 | 75 | 18.38 | 38 | 48.37 | 39 | 9.56 | 105 | 44.68 | 33 | 14.04 | 12 | 5.11 | 6 | 60 |
| Female | 206 | 50.49 | 126 | 40.07 | 75 | 18.38 | 27 | 68.08 | 50 | 12.25 | 130 | 55.32 | 39 | 16.60 | 15 | 6.38 | 4 | 40 |
Respondents’ level of awareness of Western-Korean collaborative treatment, preferred treatment method, opinion on one-stop collaborative treatment, and intention for use in the future.
| Level of Western-Korean collaborative treatment awareness | ||||||||
| No recognition | Recognition & no experience | Recognition & experience | Total | |||||
| n | (%) | n | (%) | n | (%) | n | (%) | |
| Preferred collaborative treatment method | ||||||||
| Select one from conventional or Korean medicine and receive treatment from the corresponding institution only | 123 | 25.10 | 88 | 19.34 | 9 | 14.29 | 220 | 21.83 |
| Existing Western-Korean collaborative treatment method in which some of the respective treatments of Western medicine and Korean medicine are added according to the patient's needs | 89 | 18.16 | 81 | 17.80 | 21 | 33.33 | 191 | 18.95 |
| Integrative healthcare system in which the medical specialists of conventional medicine and Korean medicine are present at one location and concurrently participate in the treatment with communication | 267 | 54.49 | 286 | 62.86 | 32 | 50.79 | 585 | 58.04 |
| Other | 9 | 1.84 | 0 | 0.00 | 1 | 1.59 | 10 | 0.99 |
| No response | 2 | 0.41 | 0 | 0.00 | 0 | 0.00 | 2 | 0.20 |
| Opinions on the collaborative treatment of Western-Korean medical staff performed concurrently at one-stop | ||||||||
| Very positive | 83 | 16.94 | 102 | 22.42 | 15 | 23.81 | 200 | 19.84 |
| Positive | 232 | 47.35 | 241 | 52.97 | 27 | 42.86 | 500 | 49.60 |
| Average | 107 | 21.84 | 67 | 14.73 | 18 | 28.57 | 192 | 19.05 |
| Negative | 24 | 4.90 | 22 | 4.84 | 2 | 3.17 | 48 | 4.76 |
| Very negative | 3 | 0.61 | 9 | 1.98 | 0 | 0.00 | 12 | 1.19 |
| No idea/do not wish to answer | 41 | 8.37 | 14 | 3.08 | 1 | 1.59 | 56 | 5.56 |
| Intention for use in the future | ||||||||
| Yes | 313 | 63.88 | 348 | 76.48 | 49 | 77.78 | 710 | 70.44 |
| No | 31 | 6.33 | 30 | 6.59 | 3 | 4.76 | 64 | 6.35 |
| No idea | 146 | 29.80 | 77 | 16.92 | 11 | 17.46 | 234 | 23.21 |
Respondents’ intention to use one-stop collaborative treatment in the future.
| Univariate | Multivariate∗ | |||
| OR | 95% CI | OR | 95% CI | |
| Age (ref. 35≤ < 40) | ||||
| 40≤ < 50 | 1.18 | (0.77–1.82) | ||
| 50≤ < 60 | 1.24 | (0.80–1.92) | ||
| 60≤ < 70 | 1.14 | (0.71–1.84) | ||
| 70≤ < 75 | 0.43 | (0.23–0.78) | 0.38 | (0.20–0.71) |
| Area (ref. Seoul) | ||||
| Incheon/Gyeonggi | 1.08 | (0.73–1.60) | ||
| Pusan/Daegu/Ulsan/Gyeongsang | 1.17 | (0.89–1.76) | ||
| Gwangju/Jeolla | 1.17 | (0.69–1.97) | ||
| Daejeon/Sejong/Chungcheong | 1.20 | (0.71–2.03) | ||
| Gangwon/Jeju | 1.37 | (0.65–2.89) | ||
| Korean medicine hospital experience (ref. None) | 1.80 | (1.27–2.56) | 1.73 | (1.12–2.68) |
| History of spine and joint disease (ref. None) | 1.34 | (1.02–1.76) | ||
| Recognition or experience of collaborative treatment (ref. No knowledge, first heard today) | ||||
| Recognizes the collaborative treatment but has no experience | 1.84 | (1.38–2.44) | 1.82 | (1.37–2.44) |
| Recognizes the collaborative treatment and has experience | 1.98 | (1.06–3.69) | ||